ChemLifeIntel
CHEMICAL & LIFE SCIENCES INTELLIGENCE
Access
ChemLifeIntel/Companies/Greenstone Llc

Greenstone Llc

HIGH RISKHQ: — · Private · Founded —
LISTINGPrivateFOUNDED0
FOCUS THERAPY AREAS
Manufacturer
COMPANY INTELLIGENCE SNAPSHOTlive
0
Manufacturing Sites
1
Intelligence Briefs
0
Active Regulatory Actions
HQ Country
NO ACTIVE REGULATORY ACTIONSClean compliance footprint across 0 monitored sites · HQ
View regulatory detail

INTELLIGENCE

Showing 1 of 1 briefs on Greenstone Llc
REGULATORY INTELLIGENCE·Recall

Greenstone Llc Initiates Nationwide Class II Recall of Methylprednisolone Tablets Due to Critical Labeling Error

Greenstone Llc has initiated a voluntary Class II nationwide recall (D-0299-2026) for 3,456 cartons of methylprednisolone tablets, USP Dosepak, 4 mg. The recall stems from an incorrect orientation of the blister foil, leading to erroneous dosing instructions. This packaging error, affecting Lot # LG7675, Exp. Date Nov 2026, poses a risk of incorrect medication administration, necessitating immediate action from procurement and regulatory teams to assess supply chain integrity and patient safety protocols.

90-Day Activity
Greenstone LlcMethylprednisolone Acetate
RMRohan Mehta· Senior Supply Chain Intelligence Analyst
2026-02-04